Mirum Pharmaceuticals, Inc. · NASDAQ:MIRM
Eventide Asset Management, LLC reported a 5.43% stake in Mirum Pharmaceuticals, Inc. (Schedule 13G/A)
Event Dec 31, 2024 · Filed Feb 14, 2025
Eventide Asset Management, LLC reported a 5.43% stake in Mirum Pharmaceuticals, Inc., 2,606,938 shares, as a passive investor on Dec 31, 2024. Filed Feb 14, 2025 (Schedule 13G/A).
- Stake
- 5.43%
- Shares
- 2,606,938
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Eventide Asset Management, LLC | 5.43% | 2,606,938 |
| Finny Kuruvilla, M.D., Ph. D. | 5.43% | 2,606,938 |
| Robin C. John | 5.43% | 2,606,938 |
Source
Related
- Mirum Pharmaceuticals, Inc.
- Eventide Asset Management, LLC
- Mirum Pharmaceuticals, Inc. shareholders
- Schedule 13G/A · Eventide Asset Management, LLC · Feb 13, 2026
- Form 4 · Howe Jolanda · Oct 19, 2026
- Form 4 · Peetz Christopher · Oct 6, 2026
- Form 4 · Bjerkholt Eric · Sep 15, 2026
- Form 4 · Howe Jolanda · Sep 3, 2026
- Form 4 · Peetz Christopher · Sep 3, 2026